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Diagnoses of Shigella flexneri in the United Kingdom 
(UK) are usually travel-related. However, since 2009, 
there has been an overall increase in UK-acquired 
cases. The Health Protection Agency has been inves-
tigating a national outbreak of S.  flexneri detected in 
2011 and which is still ongoing. Cases occurred mostly 
in men who have sex with men and were of serotype 
3a. The investigation aimed at obtaining epidemiologi-
cal data to inform targeted outbreak management and 
control.
Cases of Shigella flexneri in the United Kingdom (UK) 
usually originate from travel or contact with travellers 
from higher incidence regions such as Indian subcon-
tinent, North and East Africa and South America [1]. 
Following analyses of laboratory data, an increase in 
UK-acquired S.  flexneri cases was detected in London 
in November 2010. A subsequent rise in UK-acquired 
cases was also noted in Manchester in May 2011. The 
initial cases reported were predominantly of serotype 
3a and mostly among men who have sex with men 
(MSM) aged between 30 and 50 years, some of whom 
were HIV positive. Pulsed field gel electrophoresis 
(PGFE) performed on initial stool specimen showed 
that some of the isolates were indistinguishable, how-
ever preliminary investigation failed to identify a com-
mon venue or point source [2,3].
In response, a national outbreak control team was for-
mally established in September 2011 to investigate and 
manage the outbreak of S.  flexneri. Enhanced surveil-
lance was initiated in order to:
•	 describe the epidemiology of S. flexneri infection in 
individuals who had no travel history or who had 
travelled to countries with low risk for infection;
•	 estimate the proportion of UK-acquired cases or 
cases associated with travel in low-risk countries 
that are explained by transmission in MSM;
•	 identify risk factors for transmission of S.  flexneri 
between MSM.
Sexual transmission of Shigella was first described 
in the United States during the 1970s [4]. Since then, 
several outbreaks of sexually transmitted Shigella, 
predominantly in MSM, have been reported [5-8]. In 
2006, an outbreak of Shigella among MSM in London 
coincided with a similar outbreak in Berlin suggesting 
that travel plays a role in introducing Shigella species 
to populations at risk [9,10].
Outbreak investigation
National enhanced surveillance of S.  flexneri was con-
ducted from September to December 2011 inclusive, in 
order to describe and monitor the epidemiology of the 
outbreak. The population under surveillance consisted 
of UK-acquired S. flexneri infection cases and reported 
cases associated with travel in low-risk countries.
Low-risk travel-associated individuals were defined 
as individuals who returned to the UK in the four days 
before onset of illness after travel to countries with 
low risk for Shigella infection (Europe, North America 
and Australia). High-risk travel-associated diagnoses 
were defined as individuals who returned to the UK 
in the four days before onset of illness after travel to 
countries with high risk for Shigella infection (South 
America, Asia and Africa) [1].
A confirmed case was defined as a laboratory-
confirmed case of S.  flexneri with a specimen date 
2 www.eurosurveillance.org
between 1 September and 31 December 2011 with no 
recent travel or who reported recent travel to low-risk 
countries.
A probable case was defined as a laboratory-confirmed 
case of S. flexneri with an unknown travel history.
Cases of S.  flexneri among people who had travelled 
to high-risk countries or secondary cases of S. flexneri 
who were contacts of high risk travel-associated cases 
were excluded.
All laboratories were asked to notify Shigella isolations 
and to send stool specimens to the national reference 
laboratory (Gastrointestinal Infections Reference Unit, 
Health Protection Agency - Colindale, London) for sero-
typing, PFGE analysis and sensitivity testing. Weekly 
updates on laboratory-confirmed S. flexneri diagnoses 
were forwarded to the respective regions for further 
follow-up.
Local health protection units confirmed the travel his-
tory for every reported S.  flexneri diagnosis and con-
ducted an interview using a surveillance questionnaire 
for UK-acquired or low-risk travel-associated diagnoses 
of S.  flexneri. The questionnaire contained additional 
questions on exposures such as travel, food history, 
contact with symptomatic individuals and sexual con-
tact to assist with case management. In-depth inter-
views with confirmed MSM cases were also conducted 
to identify potential risk factors for infection.
S.  flexneri reports from the national laboratory data-
bases, regions and local units were collected and ana-
lysed and feedback was disseminated to the regional 
units and identified leads through epidemiological 
update reports.
Increased awareness and guidance for health pro-
fessionals and people at risk of infection was issued 
through HPA briefings, information leaflets and press 
releases [11].
S.  flexneri diagnoses reported by the national labora-
tories between 2001 and 2011 were also analysed to 
provide context to the current outbreak and to produce 
historical time trends.
Results
During the enhanced surveillance period between 
September and December 2011, 145 S.  flexneri diag-
noses were reported of which 37 (25.5%) were non-
travel related. Thirty-one cases were confirmed as 
being UK-acquired whereas six reported diagnoses 
were likely to be secondary cases linked to a sympto-
matic contact with recent travel to a high-risk country.
Eighty-six cases (59.3%) were associated with travel to 
high-risk countries and the travel history was unknown 
for 22 individuals (15.2%). No low-risk travel-asso-
ciated cases of S.  flexneri were reported during the 
enhanced surveillance period.
The UK-acquired cases were predominantly male 
(n=26) whereas travel-associated S. flexneri diagnoses 
were equally distributed between both sexes: 48% 
male (n=40) and 52% female (n=43) as shown in Figure 
1. The sex and age of three travel-associated cases was 
not known.
Figure 1
Cases of Shigella flexneri reported during the enhanced surveillance period by age group and sex, England and Wales, 
September – December 2011
a The gender and age of three travel-associated cases was not known.  
Source: National reference laboratory database (GDW- Gastro Data Warehouse), Health Protection Agency, Colindale, United Kingdom.
 National laboratory reporting database (LabBase 2), Health Protection Agency, Colindale, United Kingdom.
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Eleven male cases with UK-acquired S. flexneri reported 
MSM activity in the week before developing gastroen-
teritis. Three individuals refused to disclose their sex-
ual orientation.
Ten of the 31 reported UK-acquired S.  flexneri cases 
were serotype 3a, seven were serotype 1b, five were 
serotype 2a, three were serotype 6 and one case was 
reported for serotypes 1a, 1c, 2b and 3b. The serotype 
was unknown for two reported S.  flexneri diagnoses. 
More than half (n=5) of the infections in MSM were 
caused by serotype 3a, four by serotype 1b, one by 
serotype 2a and one by serotype 6.
In depth interviews with seven MSM cases showed that 
they all had one long term partner and attended regu-
lar medical examinations. However, all cases reported 
having a casual sexual partner in the week preceding 
illness. These interviews revealed lack of awareness 
about Shigella and of the risks associated with unpro-
tected oral and oral-anal sex.
Trends in S. flexneri diagnoses reported between 2001 
and 2011 showed a gradual increase in the number of 
cases with no or unknown history of travel since 2001, 
with a similar trend in both sexes until 2008 (Figure 2). 
However, from 2009 onwards, numbers of diagnoses 
rose far more rapidly in men (Figure 2).
Data analysis revealed similar trends in cases between 
sexes and within the same age group, however, since 
2009 the increase in the number of S.  flexneri cases 
reported was attributable to an overrepresentation of 
men aged between 31 and 50 years (Figure 3). 
Figure 4 shows the number of S.  flexneri diagnoses 
by serotype from 2004 to 2011. The number of cases 
infected with serotype 3a has increased consider-
ably and as from 2009 it has become as predominant 
as the 2a serotype and accounted for the increase in 
S. flexneri cases between 2009 and 2011.
The increase in serotype 3a since 2009 was mostly 
attributable to diagnoses among men aged 30-50 
years which constituted 65% (211/324) of all S. flexneri 
3a reports with no or unknown travel history between 
2009 and 2011. When focusing on the male adult cases 
with serotype 3a, the number of monthly S.  flexneri 
diagnoses in 2007/2008 fluctuates between 1 and 
7 cases. The number of monthly reports increases to 
between 5 and 15 from 2009 onwards. The following 
graph shows the number of monthly diagnoses from 
Figure 2
Shigella flexneri cases with no or unknown travel history 
stratified by year and sex, England and Wales, 2001–2011 
(n=3,352)
Source: National laboratory reporting database (LabBase 2), 
Health Protection Agency, Colindale, United Kingdom.
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Figure 3
Shigella flexneri cases by sex and age group, England and Wales, (A) 2001–2008 (n=2,026) and (B) 2009–2012 (n=1,239)
Source: National laboratory reporting database (LabBase 2), Health Protection Agency, Colindale, United Kingdom.
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2007-2012 and a three-month moving average (Figure 
5).
Control measures
The outbreak control team introduced control meas-
ures which focused on actions aimed at prompt and 
effective management of cases to prevent onward 
transmission. They included increasing awareness 
among clinicians and MSM and prompt diagnosis and 
treatment, increased testing of MSM with diarrhoea 
and treatment of laboratory-confirmed cases with cip-
rofloxacin [12] subject to antimicrobial sensitivity.
These actions also included recommendations regard-
ing behaviours that may contribute to prevent further 
transmission:
•	 wash hands after using toilet, before preparing or 
eating food and after sexual activity;
•	 avoid anal sex, oral-anal sex, scat and rimming 
whilst symptomatic and until test for infection 
shows clearance;
•	 use of condoms, gloves, dental dams during sex;
•	 avoid sharing douching materials and sex toys;
•	 avoid swimming pools and spa centres whilst ill and 
for two weeks after recovery. 
Work is ongoing to identify risk factors for infection 
and evaluate other possible control measures such as 
screening of asymptomatic contacts.
Discussion and conclusion
As the outbreak is still ongoing and no similar 
S.  flexneri outbreaks have recently been reported by 
other countries, increased vigilance and monitoring 
by other European countries is recommended in order 
to promptly and effectively detect any change in the 
reported trends of S. flexneri.
Although some people may have been reluctant to 
disclose details about their sexual orientation, the 
enhanced surveillance revealed a strong association 
between UK-acquired S.  flexneri and transmission 
in MSM. The outbreak will continue to be monitored 
through routine arrangements and information on 
cases occurring in MSM will continue to be collected 
in order to effectively describe the epidemiology of the 
disease in MSM and identify any potential risk factors 
to inform public health action.
Figure 4
Shigella flexneri serotype by year of report for cases with 
S. flexneri infection with no or unknown travel history, 
England and Wales, 2004-2011 (n=2,350)
Source: National reference laboratory database (GDW- Gastro 
Data Warehouse), Health Protection Agency, Colindale, United 
Kingdom.
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Figure 5
Adult male cases of Shigella flexneri 3a infection with no or unknown travel history, England and Wales, January 2007–
January 2012 (n=381) 
Source: National reference laboratory database (GDW- Gastro Data Warehouse), Health Protection Agency, Colindale, United Kingdom.
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Although the S. flexneri outbreak first emerged in 2009 
and has been sustained since then, it has only been 
detected relatively recently. An evaluation of Shigella 
infection surveillance will therefore be carried out in 
order to identify factors leading to the delay in out-
break identification and to explore new approaches to 
routine surveillance of sexually-transmitted Shigella 
infection. 
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